# Scribe Therapeutics Inc. Common Stock (SCTX)

> Scribe Therapeutics Inc. Common Stock (SCTX) trades at $14.25 (-9.64%) as of 4:24:20 AM EST on Nov 19, 2026, -29.08% over the past month. Market cap is $266.07M, with 4.0 days to cover in short interest.

Canonical: https://massive.com/quote/sctx
Data as of: 2026-11-19T09:24:20.387Z (15-minute delayed)
Source: Massive (https://massive.com/docs/llms.txt)

## Price

**$14.25** -1.52 (-9.64%)
As of 4:24:20 AM EST on Nov 19, 2026 · 15-minute delayed
Nasdaq · usd

## Stock performance

How Scribe Therapeutics Inc. Common Stock (SCTX) stock has performed from one day to one year, with its 52-week range.

| Period | Return |
| --- | --- |
| 1D | -10.91% |
| 1W | -16.67% |
| 1M | -29.08% |
| YTD | -35.10% |
| 1Y | -35.10% |
| 52-wk range | $13.50 – $39.60 |

From daily closes through Nov 18, 2026.

## Key statistics

Today's trading snapshot for SCTX: day range, open, previous close, volume and market cap.

| Measure | Value |
| --- | --- |
| Day range | $14.00 – $16.34 |
| Open | $15.78 |
| Prev close | $15.77 |
| Volume | 273.26K |
| Market cap | $266.07M |
| Shares out | 18.94M |

## Insider trading

[Scribe Therapeutics Inc. Common Stock (SCTX) insider trading](https://massive.com/quote/sctx/insider-trading.md): open-market Form 4 buys and sells by Scribe Therapeutics Inc. Common Stock insiders over the last 12 months.

## 8-K filings

Material corporate events Scribe Therapeutics Inc. Common Stock has disclosed to the SEC on Form 8-K.

- Nov 12, 2026 · [Quarterly earnings](https://massive.com/quote/sec-filings/8-k/earnings-releases.md)
  “On November 12, 2026, Scribe Therapeutics Inc. (the "Company") announced its financial results for the quarter ended September 30, 2026 and provided a business update.”
- Sep 2, 2026 · [Quarterly earnings](https://massive.com/quote/sec-filings/8-k/earnings-releases.md)
  “On September 2, 2026, Scribe Therapeutics Inc. (the "Company") announced its financial results for the quarter ended June 30, 2026 and provided a business update.”
- Jul 27, 2026 · Charter amendment
  “On July 27, 2026, Scribe Therapeutics Inc. (the "Company") filed its Amended and Restated Certificate of Incorporation (the "Charter") with the Secretary of State of the State of Delaware... in connection with the closing of the initial public offering (the "Offering") of shares of the Company's common stock.”

## SCTX short interest

How heavily SCTX is shorted: shares short, days to cover and average daily volume.

| Measure | Value |
| --- | --- |
| Days to cover | 4.0 |
| Short interest | 1.67M |
| Avg volume | 417.04K |

As of Oct 30, 2026 · reported to FINRA twice monthly.

## SCTX news

The latest news and headlines about Scribe Therapeutics Inc. Common Stock (SCTX).

- [Cathie Wood Bought Just 3 Stocks On Monday; Here They Are](https://www.fool.com/investing/2026/11/10/cathie-wood-bought-just-3-stocks-on-monday-here-they-are/?source=iedfolrf0000001) · The Motley Fool · Nov 10, 2026 · neutral sentiment

## About Scribe Therapeutics Inc. Common Stock

Scribe Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of in vivo CRISPR-based genetic medicines. Its research and development activities focus on cardiovascular and metabolic diseases, including atherosclerotic cardiovascular disease (ASCVD). The company's product pipeline includes STX-1150, a CRISPR-based product candidate that utilizes its ELXR epigenetic silencing technology.

| Measure | Value |
| --- | --- |
| Exchange | Nasdaq |
| Market | stocks |
| Type | CS |
| Currency | USD |
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| IPO | $15.00 on Jul 24, 2026 |

[Scribe Therapeutics IPO page](https://massive.com/quote/sctx/ipo.md)

[Company website](https://www.scribetx.com)

## FAQ

### What is the Scribe Therapeutics Inc. Common Stock (SCTX) stock price today?

Scribe Therapeutics Inc. Common Stock (SCTX) is trading at $14.25 (-9.64% on the day) as of 4:24:20 AM EST on Nov 19, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

### What is Scribe Therapeutics Inc. Common Stock?

Scribe Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of in vivo CRISPR-based genetic medicines. Its research and development activities focus on cardiovascular and metabolic diseases, including atherosclerotic cardiovascular disease…

### What is the short interest in SCTX?

As of Oct 30, 2026, SCTX has 1.67M shares short and 4.0 days to cover.

### What exchange is SCTX listed on?

Scribe Therapeutics Inc. Common Stock (SCTX) trades on Nasdaq in USD, in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry.

## Live data

Prices here are 15-minute delayed. For real-time SCTX quotes and the full history behind this page, use the Massive API or MCP server:

- `GET https://api.massive.com/v3/snapshot?ticker.any_of=SCTX`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [Scribe Therapeutics Inc. Common Stock (SCTX) insider trading](https://massive.com/quote/sctx/insider-trading.md)
- [SEC 8-K events](https://massive.com/quote/sec-filings/8-k.md)
- [Markets overview](https://massive.com/quote/index.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms
